Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP343937.RAAs_l86E9uNcT0G_HpGLsmbIAGGUbJTcp79buW-swZxk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP343937.RAAs_l86E9uNcT0G_HpGLsmbIAGGUbJTcp79buW-swZxk130_assertion type Assertion NP343937.RAAs_l86E9uNcT0G_HpGLsmbIAGGUbJTcp79buW-swZxk130_head.
- NP343937.RAAs_l86E9uNcT0G_HpGLsmbIAGGUbJTcp79buW-swZxk130_assertion description "[Patients with Gaucher disease were shown to have an increased 16:0-glucosylceramide/16:0-lactosylceramide ratio and elevated concentrations of LAMP-1 and saposin C in plasma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP343937.RAAs_l86E9uNcT0G_HpGLsmbIAGGUbJTcp79buW-swZxk130_provenance.
- NP343937.RAAs_l86E9uNcT0G_HpGLsmbIAGGUbJTcp79buW-swZxk130_assertion evidence source_evidence_literature NP343937.RAAs_l86E9uNcT0G_HpGLsmbIAGGUbJTcp79buW-swZxk130_provenance.
- NP343937.RAAs_l86E9uNcT0G_HpGLsmbIAGGUbJTcp79buW-swZxk130_assertion SIO_000772 11825063 NP343937.RAAs_l86E9uNcT0G_HpGLsmbIAGGUbJTcp79buW-swZxk130_provenance.
- NP343937.RAAs_l86E9uNcT0G_HpGLsmbIAGGUbJTcp79buW-swZxk130_assertion wasDerivedFrom befree-2016 NP343937.RAAs_l86E9uNcT0G_HpGLsmbIAGGUbJTcp79buW-swZxk130_provenance.
- NP343937.RAAs_l86E9uNcT0G_HpGLsmbIAGGUbJTcp79buW-swZxk130_assertion wasGeneratedBy ECO_0000203 NP343937.RAAs_l86E9uNcT0G_HpGLsmbIAGGUbJTcp79buW-swZxk130_provenance.